Medications for Attention Deficit Hyperactivity Disorder

100 results
  • Granules Pharmaceuticals Inc.
    Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity in conjunction with a comprehensive treatment program, and as a short-term adjunct for exogenous obesity in patients not responding to other weight loss strategies.
  • Bryant Ranch Prepack
    Usage: Amphetamine sulfate tablets are indicated for narcolepsy, attention deficit disorder with hyperactivity as part of a comprehensive treatment program, and short-term treatment of exogenous obesity alongside caloric restriction for patients not responding to other weight loss methods.
  • Lannett Company, Inc.
    Usage: Amphetamine sulfate tablets (5 mg and 10 mg) are indicated for narcolepsy, Attention Deficit-Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term management of exogenous obesity as an adjunct to a caloric restriction regimen in patients unresponsive to other therapies.
  • Burel Pharmaceuticals, LLC
    Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients (ages 6-18) and adults. It should be part of a comprehensive treatment program, possibly including psychological, educational, and social measures, and is not suited for patients with ADHD symptoms due to environmental factors or other disorders.
  • AvPAK
    Usage: Atomoxetine is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in both pediatric and adult patients. It is part of a comprehensive treatment program, which may include psychological, educational, and social interventions. Drug treatment is not intended for symptoms solely due to environmental factors or other psychiatric disorders.
  • A-S Medication Solutions
    Usage: Atomoxetine is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients (ages 6 to 18) and adults. It is part of a comprehensive treatment program that may include psychological and educational interventions, tailored to the patient's severity and chronicity of symptoms.
  • REMEDYREPACK INC.
    Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients (ages 6-18) and adults. The drug is part of a comprehensive treatment program, which may include psychological, educational, and social measures, and is not suitable for patients with symptoms due to environmental factors or other psychiatric disorders.
  • Sandoz Inc
    Usage: Atomoxetine hydrochloride is indicated for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients aged 6 to 18 and adults. It is part of a comprehensive treatment program, which may include psychological, educational, and social interventions, especially when drug treatment is deemed necessary based on symptom severity.
  • Apotex Corp.
    Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric and adult patients. It should be part of a comprehensive treatment program that may include psychological, educational, and social interventions, and is not suitable for those with symptoms due to environmental factors or other psychiatric disorders.
  • Azstarys

    (Serdexmethylphenidate and Dexmethylphenidate)
    Corium, LLC.
    Usage: AZSTARYS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older.